How Does the Maternal Immune System Contribute to the Development of Pre-eclampsia?

Placenta

Volumn 28, Issue SUPPL., 2007, Pages

  Moffett, A ^a   Hiby, S E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

HLA C; Killer immunoglobulin like receptor; NK cell; Pre eclampsia; Trophoblast

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; NATURAL KILLER CELL RECEPTOR;

ALLOIMMUNITY; ANTIGEN RECOGNITION; ARTICLE; CELL INTERACTION; CELL INVASION; FETOPLACENTAL UNIT; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOPATHOGENESIS; INCIDENCE; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TROPHOBLAST;

FEMALE; FETUS; HLA ANTIGENS; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, IMMUNOLOGIC; TROPHOBLASTS;

EID: 33947723698     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2006.11.008     Document Type: Article

References (29)

1. Pijnenborg R., Vercruysse L., and Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27 (2006) 939-958
2. Redman C.W. Immunology of preeclampsia. Semin Perinatol 15 (1991) 257-262
3. Walker J.J. Pre-eclampsia. Lancet 356 (2000) 1260-1265
4. Robertson W.B., Brosens I., Pijnenborg R., and De Wolf F. The making of the placental bed. Eur J Obstet Gynecol Reprod Biol 18 (1984) 255-266
5. Papageorghiou A.T., Yu C.K., and Nicolaides K.H. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 18 (2004) 383-396
6. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2 (2002) 656-663
7. MacGillivray I. Some observations on the incidence of pre-eclampsia. J Obstet Gynaecol Br Emp 65 (1958) 536-539
8. Trogstad L. The paternal role in pre-eclampsia. In: Critchley H., MacLean A., Poston L., and Walker J. (Eds). Pre-eclampsia (2003), RCOG Press 208-224
9. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
10. Mostello D., Catlin T.K., Roman L., Holcomb Jr. W.L., and Leet T. Preeclampsia in the parous woman: who is at risk?. Am J Obstet Gynecol 187 (2002) 425-429
11. Hjartardottir S., Leifson B.G., Geirsson R.T., and Steinthorsdottir V. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol 194 (2006) 916-920
12. Dekker G., and Robillard P.Y. The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis. J Reprod Immunol 59 (2003) 245-251
13. Trupin L.S., Simon L.P., and Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology 7 (1996) 240-244
14. Li DK, Wi, S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol 151;57-62.
15. Salha O., Sharma V., Dada T., Nugent D., Rutherford A.J., Tomlinson A.J., et al. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod 14 (1999) 2268-2273
16. Esplin M.S., Fausett M.B., Fraser A., Kerber R., Mineau G., Carrillo J., et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 344 (2001) 867-872
17. Skjaerven R., Vatten L.J., Wilcox A.J., Ronning T., Irgens L.M., and Lie R.T. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 331 (2005) 877
18. Alderman B.W., Sperling R.S., and Daling J.R. An epidemiological study of the immunogenetic aetiology of pre-eclampsia. Br Med J (Clin Res Ed) 292 (1986) 372-374
19. Caughey A.B., Stotland N.E., Washington A.E., and Escobar G.J. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol 106 (2005) 156-161
20. Medawar P. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 7 (1953) 320-328
21. Parham P. Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response. Immunol Lett 29 (2004) 11-13
22. Bashirova A.A., Martin M.P., McVicar D.W., and Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 7 (2006) 277-300
23. Hiby S.E., Walker J., O'Shaughnessy K.M., Redman C.W.G., Carrington M., Trowsdale J., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200 (2004) 957-965
24. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005) 201-214
25. Li X.F., Charnock-Jones D.S., Zhang E., Hiby S., Malik S., Day K., et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 86 (2001) 1823-1834
26. Koopman L.A., Kopcow H.D., Rybalov B., Boyson J.E., Orange J.S., Schatz F., et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198 (2003) 1201-1212
27. Lash G.E., Schiessl B., Kirkley M., Innes B.A., Cooper A., Searle R.F., et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol 80 (2006) 572-580
28. Hanna J., Goldman-Wohl D., Hamani Y., Avraham I., Greenfield C., Natanson-Yaron S., et al. Decidual NK cells regulate key developmental processes in the human fetal-maternal interface. Nat Med 12 (2006) 1065-1074
29. Lie R.T., Rasmussen S., Brunborg H., Gjessing H.K., Lie-Nielsen E., and Irgens L.M. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 316 (1998) 1343-1347